NDC 0169-2911
Xultophy 100/3.6 3.6 mg per 1 mL / 100 [iU] per 1 mL injection, solution
On the label: Novo Nordisk.
Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Novo Nordisk names for other drugs.
Recalls
- Mar 22, 2021 · Class I · Novo Nordisk Inc
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Lots: JP54291, exp 06/20/2021
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Insulin Degludec and Liraglutide: every company that makes it
- Form
- injection, solution, subcutaneous
- Strength
- 3.6 mg per 1 mL / 100 [iU] per 1 mL
- Approval
- BLA BLA208583
- On the market since
- Nov 21, 2016
- Package NDCs
0169-2911-150169-2911-900169-2911-97- Official label
- DailyMed (National Library of Medicine), updated Oct 14, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?